Another clinical trial found that 50 mg of oral Wegovy reduced peoples caloric intake by nearly 40% in 20 weeks, leading to an average weight loss of 9.8%
The medication also improves cardiovascular outcomes and reduces inflammation markers associated with obesity-related diseases
We know about these interactions because Novo Nordisk, the manufacturer of FDA-approved Wegovy, Ozempic, and Rybelsus, is required to report adverse events to the FDA
So, why does this weight gain happen, and how can you prevent it from even occurring
Regeneron, which has a market cap of $77 billion, will be in charge of future development and any commercialization of the gene therapy
But losing too much weight to the point where youre underweight isnt good either, and can cause your period to stop altogether